ASCO GU 2022 Updates on the Phase 3 TITAN Study: The Effect of Prior Docetaxel Treatment on Efficacy & Safety of Apalutamide + ADT in mCSPC

167 views
March 14, 2022
Comments 0
Login to view comments. Click here to Login